Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1984 Jan;39(1):1–7. doi: 10.1136/thx.39.1.1

Therapeutic aerosols 2--Drugs available by the inhaled route.

S W Clarke, S P Newman
PMCID: PMC459712  PMID: 6141646

Full text

PDF
2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altounyan R. E. Review of clinical activity and mode of action of sodium cromoglycate. Clin Allergy. 1980 Jul;10 (Suppl):481–489. doi: 10.1111/j.1365-2222.1980.tb02162.x. [DOI] [PubMed] [Google Scholar]
  2. Anderson S. D., Seale J. P., Rozea P., Bandler L., Theobald G., Lindsay D. A. Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Respir Dis. 1976 Sep;114(3):493–500. doi: 10.1164/arrd.1976.114.3.493. [DOI] [PubMed] [Google Scholar]
  3. Barger G., Dale H. H. Chemical structure and sympathomimetic action of amines. J Physiol. 1910 Oct 11;41(1-2):19–59. doi: 10.1113/jphysiol.1910.sp001392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bohadana A. B., Peslin R., Teculescu D., Polu J. M., Belleville F., Massin N. The bronchodilator action of theophylline aerosol in subjects with chronic airflow obstruction. Bull Eur Physiopathol Respir. 1980 Jan-Feb;16(1):13–24. [PubMed] [Google Scholar]
  5. Clark T. J. Safety of inhaled corticosteroids. Eur J Respir Dis Suppl. 1982;122:235–242. [PubMed] [Google Scholar]
  6. Clarke C. H., Nicholson A. N. Performance studies with antihistamines. Br J Clin Pharmacol. 1978 Jul;6(1):31–35. doi: 10.1111/j.1365-2125.1978.tb01678.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clarke S. W., Lopez-Vidriero M. T., Pavia D., Thomson M. L. The effect of sodium 2-mercapto-ethane sulphonate and hypertonic saline aerosols on bronchial clearance in chronic bronchitis. Br J Clin Pharmacol. 1979 Jan;7(1):39–44. doi: 10.1111/j.1365-2125.1979.tb00894.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Collier J. G., Dobbs R. J., Williams I. Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction. Br J Clin Pharmacol. 1980 Mar;9(3):273–274. doi: 10.1111/j.1365-2125.1980.tb04837.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cushley M. J., Lewis R. A., Tattersfield A. E. Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax. 1983 Dec;38(12):908–913. doi: 10.1136/thx.38.12.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Davies D. S. Pharmacokinetics of inhaled substances. Postgrad Med J. 1975;51(7 Suppl):69–75. [PubMed] [Google Scholar]
  11. Dollery C. T., Williams F. M., Draffan G. H., Wise G., Sahyoun H., Paterson J. W., Walker S. R. Arterial blood levels of fluorocarbons in asthmatic patients following use of pressurized aerosols. Clin Pharmacol Ther. 1974 Jan;15(1):59–66. doi: 10.1002/cpt197415159. [DOI] [PubMed] [Google Scholar]
  12. Douglas N. J., Sudlow M. F., Flenley D. C. Effect of an inhaled atropinelike agent on normal airway function. J Appl Physiol Respir Environ Exerc Physiol. 1979 Feb;46(2):256–262. doi: 10.1152/jappl.1979.46.2.256. [DOI] [PubMed] [Google Scholar]
  13. Edmunds A. T., Godfrey S. Cardiovascular response during severe acute asthma and its treatment in children. Thorax. 1981 Jul;36(7):534–540. doi: 10.1136/thx.36.7.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fanta C. H., McFadden E. R., Jr, Ingram R. H., Jr Effects of cromolyn sodium on the response to respiratory heat loss in normal subjects. Am Rev Respir Dis. 1981 Feb;123(2):161–164. doi: 10.1164/arrd.1981.123.2.161. [DOI] [PubMed] [Google Scholar]
  15. Fazio F., Lafortuna C. Effect of inhaled salbutamol on mucociliary clearance in patients with chronic bronchitis. Chest. 1981 Dec;80(6 Suppl):827–830. doi: 10.1378/chest.80.6.827. [DOI] [PubMed] [Google Scholar]
  16. Foster W. M., Bergofsky E. H., Bohning D. E., Lippmann M., Albert R. E. Effect of adrenergic agents and their mode of action on mucociliary clearance in man. J Appl Physiol. 1976 Aug;41(2):146–152. doi: 10.1152/jappl.1976.41.2.146. [DOI] [PubMed] [Google Scholar]
  17. Grant I. W. Asthma in New Zealand. Br Med J (Clin Res Ed) 1983 Jan 29;286(6362):374–377. doi: 10.1136/bmj.286.6362.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Harai S., Ikenaga T., Matsuzawa T. Nasal absorption of insulin in dogs. Diabetes. 1978 Mar;27(3):296–299. doi: 10.2337/diab.27.3.296. [DOI] [PubMed] [Google Scholar]
  19. Hartley J. P., Nogrady S. G. Effect of an inhaled antihistamine on exercise-induced asthma. Thorax. 1980 Sep;35(9):675–679. doi: 10.1136/thx.35.9.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hensley M. J., O'Cain C. F., McFadden E. R., Jr, Ingram R. H., Jr Distribution of bronchodilatation in normal subjects: beta agonist versus atropine. J Appl Physiol Respir Environ Exerc Physiol. 1978 Nov;45(5):778–782. doi: 10.1152/jappl.1978.45.5.778. [DOI] [PubMed] [Google Scholar]
  21. Hodges I. G., Milner A. D., Stokes G. M. Bronchodilator effect of two inhaled H1-receptor antagonists, clemastine and chlorpheniramine, in wheezy school-children. Br J Dis Chest. 1983 Jul;77(3):270–275. [PubMed] [Google Scholar]
  22. Hodson M. E., Penketh A. R., Batten J. C. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet. 1981 Nov 21;2(8256):1137–1139. doi: 10.1016/s0140-6736(81)90588-2. [DOI] [PubMed] [Google Scholar]
  23. Ingram R. H., Jr, Wellman J. J., McFadden E. R., Jr, Mead J. Relative contributions of large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol. J Clin Invest. 1977 Apr;59(4):696–703. doi: 10.1172/JCI108688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jackson R. T., Beaglehole R., Rea H. H., Sutherland D. C. Mortality from asthma: a new epidemic in New Zealand. Br Med J (Clin Res Ed) 1982 Sep 18;285(6344):771–774. doi: 10.1136/bmj.285.6344.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jones R. M., Horn C. R., Lee D. V., Brennan S. R. Bronchodilator effects of disodium cromoglycate in exercise-induced bronchoconstriction. Br J Dis Chest. 1983 Oct;77(4):362–369. [PubMed] [Google Scholar]
  26. Leifer K. N., Wittig H. J. Annals of allergy. Ann Allergy. 1975 Aug;35(2):69–80. [PubMed] [Google Scholar]
  27. Lightbody I. M., Ingram C. G., Legge J. S., Johnston R. N. Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis. Br J Dis Chest. 1978 Jul;72(3):181–186. doi: 10.1016/0007-0971(78)90039-6. [DOI] [PubMed] [Google Scholar]
  28. Lillington A. W., Campbell A. N., Poulier R. A. Safe drugs for childhood asthma? Lancet. 1983 Oct 29;2(8357):1032–1033. doi: 10.1016/s0140-6736(83)91023-1. [DOI] [PubMed] [Google Scholar]
  29. Miller W. F. Aerosol therapy in acute and chronic respiratory disease. Arch Intern Med. 1973 Jan;131(1):148–155. [PubMed] [Google Scholar]
  30. Nadel J. A. New approaches to regulation of fluid secretion in airways. Chest. 1981 Dec;80(6 Suppl):849–851. doi: 10.1378/chest.80.6.849. [DOI] [PubMed] [Google Scholar]
  31. Newman S. P., Morén F., Pavia D., Little F., Clarke S. W. Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis. 1981 Sep;124(3):317–320. doi: 10.1164/arrd.1981.124.3.317. [DOI] [PubMed] [Google Scholar]
  32. PALMER K. N. Reduction of sputum viscosity by a water aerosol in chronic bronchitis. Lancet. 1960 Jan 9;1(7115):91–91. doi: 10.1016/s0140-6736(60)92905-6. [DOI] [PubMed] [Google Scholar]
  33. Partridge M. R., Saunders K. B. Site of action of ipratropium bromide and clinical and physiological determinants of response in patients with asthma. Thorax. 1981 Jul;36(7):530–533. doi: 10.1136/thx.36.7.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Patel K. R., Tullett W. M. Bronchoconstriction in response to ipratropium bromide. Br Med J (Clin Res Ed) 1983 Apr 23;286(6374):1318–1318. doi: 10.1136/bmj.286.6374.1318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Paterson J. W., Shenfield G. M. Bronchodilators. Part II. BTTA Rev. 1974 Dec;4(4):61–74. [PubMed] [Google Scholar]
  36. Paterson J. W., Woolcock A. J., Shenfield G. M. Bronchodilator drugs. Am Rev Respir Dis. 1979 Nov;120(5):1149–1188. doi: 10.1164/arrd.1979.120.5.1149. [DOI] [PubMed] [Google Scholar]
  37. Pavia D., Bateman J. R., Clarke S. W. Deposition and clearance of inhaled particles. Bull Eur Physiopathol Respir. 1980 May-Jun;16(3):335–366. [PubMed] [Google Scholar]
  38. Pavia D., Thomson M. L., Clarke S. W. Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am Rev Respir Dis. 1978 Feb;117(2):199–203. doi: 10.1164/arrd.1978.117.2.199. [DOI] [PubMed] [Google Scholar]
  39. Prior J. G., Cochrane G. M., Raper S. M., Ali C., Volans G. N. Self-poisoning with oral salbutamol. Br Med J (Clin Res Ed) 1981 Jun 13;282(6280):1932–1932. doi: 10.1136/bmj.282.6280.1932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rodenstein D., Stănescu D. C. Mouth spraying versus inhalation of fenoterol aerosol in healthy subjects and asthmatic patients. Br J Dis Chest. 1982 Oct;76(4):365–373. doi: 10.1016/0007-0971(82)90072-9. [DOI] [PubMed] [Google Scholar]
  41. Ruffin R. E., Kenworthy M. C., Newhouse M. T. Response of asthmatic patients to fenoterol inhalation: a method of quantifying the airway bronchodilator dose. Clin Pharmacol Ther. 1978 Mar;23(3):338–345. doi: 10.1002/cpt1978233338. [DOI] [PubMed] [Google Scholar]
  42. Ruffin R. E., Montgomery J. M., Newhouse M. T. Site of beta-adrenergic receptors in the respiratory tract: use of fenoterol administered by two methods. Chest. 1978 Sep;74(3):256–260. doi: 10.1378/chest.74.3.256. [DOI] [PubMed] [Google Scholar]
  43. Ruffin R. E., Newhouse M. T. Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics. Lung. 1978;155(2):141–146. doi: 10.1007/BF02730688. [DOI] [PubMed] [Google Scholar]
  44. Russell M. A., Sutton S. R., Iyer R., Feyerabend C., Vesey C. J. Long-term switching to low-tar low-nicotine cigarettes. Br J Addict. 1982 Jun;77(2):145–158. doi: 10.1111/j.1360-0443.1982.tb01416.x. [DOI] [PubMed] [Google Scholar]
  45. Sackner M. A., Silva G. Effects of terbutaline aerosol in reversible airway obstruction. Chest. 1978 Jun;73(6):802–806. doi: 10.1378/chest.73.6.802. [DOI] [PubMed] [Google Scholar]
  46. Schoeffel R. E., Anderson S. D., Altounyan R. E. Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline. Br Med J (Clin Res Ed) 1981 Nov 14;283(6302):1285–1287. doi: 10.1136/bmj.283.6302.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Smith M. J., Hodson M. E. Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax. 1983 Sep;38(9):676–681. doi: 10.1136/thx.38.9.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Smith M. J., Hodson M. E. High-dose beclomethasone inhaler in the treatment of asthma. Lancet. 1983 Feb 5;1(8319):265–269. doi: 10.1016/s0140-6736(83)91686-0. [DOI] [PubMed] [Google Scholar]
  49. Speizer F. E., Doll R., Heaf P. Observations on recent increase in mortality from asthma. Br Med J. 1968 Feb 10;1(5588):335–339. doi: 10.1136/bmj.1.5588.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Speizer F. E., Wegman D. H., Ramirez A. Palpitation rates associated with fluorocarbon exposure in a hospital setting. N Engl J Med. 1975 Mar 20;292(12):624–626. doi: 10.1056/NEJM197503202921207. [DOI] [PubMed] [Google Scholar]
  51. Stableforth D. Death from asthma. Thorax. 1983 Nov;38(11):801–805. doi: 10.1136/thx.38.11.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Tashkin D. P., Trevor E., Chopra S. K., Taplin G. V. Sites of airway dilatation in asthma following inhaled versus subcutaneous terbutaline. Comparison of physiologic tests with radionuclide lung images. Am J Med. 1980 Jan;68(1):14–26. doi: 10.1016/0002-9343(80)90156-4. [DOI] [PubMed] [Google Scholar]
  53. Toogood J. H. Concentrated aerosol formulations in asthma. Lancet. 1983 Oct 1;2(8353):790–791. doi: 10.1016/s0140-6736(83)92318-8. [DOI] [PubMed] [Google Scholar]
  54. Toogood J. H., Jennings B., Baskerville J., Johansson S. A. Clinical use of spacer systems for corticosteroid inhalation therapy: a preliminary analysis. Eur J Respir Dis Suppl. 1982;122:100–107. [PubMed] [Google Scholar]
  55. Ullah M. I., Newman G. B., Saunders K. B. Influence of age on response to ipratropium and salbutamol in asthma. Thorax. 1981 Jul;36(7):523–529. doi: 10.1136/thx.36.7.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Ward M. J., Fentem P. H., Smith W. H., Davies D. Ipratropium bromide in acute asthma. Br Med J (Clin Res Ed) 1981 Feb 21;282(6264):598–600. doi: 10.1136/bmj.282.6264.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Williams A. J., Baghat M. S., Stableforth D. E., Cayton R. M., Shenoi P. M., Skinner C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax. 1983 Nov;38(11):813–821. doi: 10.1136/thx.38.11.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Williams M. H., Jr Conference on the scientific basis of respiratory therapy. Aerosol therapy. Steroid and antibiotic aerosols. Am Rev Respir Dis. 1974 Dec;110(6 Pt 2):122–128. doi: 10.1164/arrd.1974.110.6P2.122. [DOI] [PubMed] [Google Scholar]
  59. Williams S., Seaton A. Intravenous or inhaled salbutamol in severe acute asthma? Thorax. 1977 Oct;32(5):555–558. doi: 10.1136/thx.32.5.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Wilson J. D., Sutherland D. C., Thomas A. C. Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma? Lancet. 1981 Jun 6;1(8232):1235–1237. doi: 10.1016/s0140-6736(81)92403-x. [DOI] [PubMed] [Google Scholar]
  61. Woolcock A. J. Inhaled drugs in the prevention of asthma. Am Rev Respir Dis. 1977 Feb;115(2):191–194. doi: 10.1164/arrd.1977.115.2.191. [DOI] [PubMed] [Google Scholar]
  62. Yeates D. B., Spektor D. M., Leikauf G. D., Pitt B. R. Effects of drugs on mucociliary transport in the trachea and bronchial airways. Chest. 1981 Dec;80(6 Suppl):870–873. doi: 10.1378/chest.80.6.870. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES